KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

National Health Investors (NHI) Cash from Investing Activities (2016 - 2025)

National Health Investors (NHI) has disclosed Cash from Investing Activities for 17 consecutive years, with -$187.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Cash from Investing Activities fell 16.02% year-over-year to -$187.0 million, compared with a TTM value of -$269.1 million through Dec 2025, down 39.95%, and an annual FY2025 reading of -$269.1 million, down 39.95% over the prior year.
  • Cash from Investing Activities was -$187.0 million for Q4 2025 at National Health Investors, down from $41.7 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $194.3 million in Q2 2022 and bottomed at -$187.0 million in Q4 2025.
  • Average Cash from Investing Activities over 5 years is -$4.5 million, with a median of -$5.6 million recorded in 2021.
  • The sharpest move saw Cash from Investing Activities skyrocketed 4901.97% in 2021, then crashed 7000.64% in 2024.
  • Year by year, Cash from Investing Activities stood at $21.9 million in 2021, then plummeted by 324.45% to -$49.2 million in 2022, then soared by 104.75% to $2.3 million in 2023, then plummeted by 7000.64% to -$161.2 million in 2024, then dropped by 16.02% to -$187.0 million in 2025.
  • Business Quant data shows Cash from Investing Activities for NHI at -$187.0 million in Q4 2025, $41.7 million in Q3 2025, and -$48.3 million in Q2 2025.